242 related articles for article (PubMed ID: 30149300)
21. Glycan analysis for protein therapeutics.
Yang X; Bartlett MG
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():29-40. PubMed ID: 31063953
[TBL] [Abstract][Full Text] [Related]
22. Hydrophobic interaction chromatography for the characterization of monoclonal antibodies and related products.
Fekete S; Veuthey JL; Beck A; Guillarme D
J Pharm Biomed Anal; 2016 Oct; 130():3-18. PubMed ID: 27084526
[TBL] [Abstract][Full Text] [Related]
23. Online Hydrophobic Interaction Chromatography-Mass Spectrometry for the Analysis of Intact Monoclonal Antibodies.
Chen B; Lin Z; Alpert AJ; Fu C; Zhang Q; Pritts WA; Ge Y
Anal Chem; 2018 Jun; 90(12):7135-7138. PubMed ID: 29846060
[TBL] [Abstract][Full Text] [Related]
24. Characterization of product-related low molecular weight impurities in therapeutic monoclonal antibodies using hydrophilic interaction chromatography coupled with mass spectrometry.
Wang S; Liu AP; Yan Y; Daly TJ; Li N
J Pharm Biomed Anal; 2018 May; 154():468-475. PubMed ID: 29587227
[TBL] [Abstract][Full Text] [Related]
25. Subunit mass analysis for monitoring multiple attributes of monoclonal antibodies.
Liu P; Zhu X; Wu W; Ludwig R; Song H; Li R; Zhou J; Tao L; Leone AM
Rapid Commun Mass Spectrom; 2019 Jan; 33(1):31-40. PubMed ID: 30286260
[TBL] [Abstract][Full Text] [Related]
26. Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation.
Goyon A; D'Atri V; Colas O; Fekete S; Beck A; Guillarme D
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1065-1066():35-43. PubMed ID: 28946123
[TBL] [Abstract][Full Text] [Related]
27. Hyphenation of size exclusion chromatography to native ion mobility mass spectrometry for the analytical characterization of therapeutic antibodies and related products.
Ehkirch A; Hernandez-Alba O; Colas O; Beck A; Guillarme D; Cianférani S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():176-183. PubMed ID: 29684909
[TBL] [Abstract][Full Text] [Related]
28. Multi-approach LC-MS methods for the characterization of species-specific attributes of monoclonal antibodies from plants.
Tengattini S; Rinaldi F; Perez-Fernandez V; Fabbri A; Donini M; Marusic C; Sferrazza G; Pierimarchi P; Zonfrillo M; Calleri E; Massolini G; Pisano C; Temporini C
J Pharm Biomed Anal; 2022 Jul; 216():114796. PubMed ID: 35550279
[TBL] [Abstract][Full Text] [Related]
29. On-line characterization of monoclonal antibody variants by liquid chromatography-mass spectrometry operating in a two-dimensional format.
Alvarez M; Tremintin G; Wang J; Eng M; Kao YH; Jeong J; Ling VT; Borisov OV
Anal Biochem; 2011 Dec; 419(1):17-25. PubMed ID: 21867674
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous screening for lipophilic and hydrophilic toxins in marine harmful algae using a serially coupled reversed-phase and hydrophilic interaction liquid chromatography separation system with high-resolution mass spectrometry.
Chen J; Gao L; Li Z; Wang S; Li J; Cao W; Sun C; Zheng L; Wang X
Anal Chim Acta; 2016 Mar; 914():117-26. PubMed ID: 26965334
[TBL] [Abstract][Full Text] [Related]
31. Comparison of originator and biosimilar therapeutic monoclonal antibodies using comprehensive two-dimensional liquid chromatography coupled with time-of-flight mass spectrometry.
Sorensen M; Harmes DC; Stoll DR; Staples GO; Fekete S; Guillarme D; Beck A
MAbs; 2016 Oct; 8(7):1224-1234. PubMed ID: 27362833
[TBL] [Abstract][Full Text] [Related]
32. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods.
Reusch D; Haberger M; Maier B; Maier M; Kloseck R; Zimmermann B; Hook M; Szabo Z; Tep S; Wegstein J; Alt N; Bulau P; Wuhrer M
MAbs; 2015; 7(1):167-79. PubMed ID: 25524468
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of coverage, retention patterns, and selectivity of seven liquid chromatographic methods for metabolomics.
Wernisch S; Pennathur S
Anal Bioanal Chem; 2016 Sep; 408(22):6079-91. PubMed ID: 27370688
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion.
Wang Y; Li X; Liu YH; Richardson D; Li H; Shameem M; Yang X
MAbs; 2016; 8(8):1477-1486. PubMed ID: 27598507
[TBL] [Abstract][Full Text] [Related]
35. Bispecific antibody characterization by a combination of intact and site-specific/chain-specific LC/MS techniques.
Duivelshof BL; Beck A; Guillarme D; D'Atri V
Talanta; 2022 Jan; 236():122836. PubMed ID: 34635226
[TBL] [Abstract][Full Text] [Related]
36. Analysis of recombinant monoclonal antibodies in hydrophilic interaction chromatography: A generic method development approach.
Bobály B; D'Atri V; Beck A; Guillarme D; Fekete S
J Pharm Biomed Anal; 2017 Oct; 145():24-32. PubMed ID: 28646659
[TBL] [Abstract][Full Text] [Related]
37. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions.
Sarrut M; Corgier A; Fekete S; Guillarme D; Lascoux D; Janin-Bussat MC; Beck A; Heinisch S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():103-111. PubMed ID: 27426266
[TBL] [Abstract][Full Text] [Related]
38. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
[TBL] [Abstract][Full Text] [Related]
39. Advanced hyphenated chromatographic-mass spectrometry in mycotoxin determination: current status and prospects.
Li P; Zhang Z; Hu X; Zhang Q
Mass Spectrom Rev; 2013; 32(6):420-52. PubMed ID: 23804155
[TBL] [Abstract][Full Text] [Related]
40. From proof of concept to the routine use of an automated and robust multi-dimensional liquid chromatography mass spectrometry workflow applied for the charge variant characterization of therapeutic antibodies.
Goyon A; Dai L; Chen T; Wei B; Yang F; Andersen N; Kopf R; Leiss M; Mølhøj M; Guillarme D; Stella C
J Chromatogr A; 2020 Mar; 1615():460740. PubMed ID: 31796250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
